Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ProTrans Repeated Treatment in Type 1 Diabetes
NCT03973827Phase 2Completed
- Sponsor
- NextCell Pharma AB
- Start
- May 2019
- Primary completion
- Dec 2020
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of ProTrans in type 1 diabetes mellitus (T1D), sponsored by NextCell Pharma AB. Started May 2019; status: completed.
02
Drugs
ProTrans
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT03973827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03973827.